The abstract is read at the publisher; the summary is JClub's.
In 2022, global cervical cancer screening coverage for women aged 30–49 years using any method was 35% (30–39) over the previous 5 years, with 38% ever screened.
- Why it matters: Progress toward WHO’s cervical cancer elimination depends on regularly updated coverage estimates, including how widely HPV test-based screening has been adopted and rolled out.
- What they did: A review and synthetic analysis estimated standardized screening coverage for 2022 across 194 WHO member states and eight associated countries/territories using programme and population data collected up to Jan 31, 2024, plus WHO consultation feedback.
- The result: HPV test-based screening coverage in the previous 5 years was 8% (6–9) globally—32% (25–40) in high-income countries versus 2% (2–3) in low- and middle-income countries—showing large disparities.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.